Investors have missed a couple of things, he says, firstly that policy is key, and that worries about a stock market that looks expensive — based on forward price earnings ratios for 2021 — matters less than the additional return they will get relative to falling bonds.+0.20% will start trials of its COVID-19 vaccine in humans after promising tests on primates, while the Food and Drug Administration is reportedly nearing emergency approval to treat COVID-19 patients with blood plasma from the recovered.